Marta Kovatcheva

@martakova.bsky.social

Group leader @IFOMresearch interested in how cell plasticity governs health, aging, and disease. Mostly here for the news and the memes. Views are my own. https://www.ifom.eu/en/cancer-research/research-labs/research-lab-kovatcheva.php

What a wonderful session! Blown away by the number of scientists that came out early this morning, and I really enjoyed our collective conversation. Thanks for the opportunity ☺️

The Mark Foundation for Cancer Research@themarkfdn.bsky.social · last yr.

We’re thrilled to be in Lisbon at #EACR2025! Today, Becky Bish cochaired a “Meet the Awardees” session featuring a (standing room only!) discussion with Karin de Visser & @martakova.bsky.social, 2025 winner of the @helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award. t.co/nU2tSzzknB

What an honor to be included in this episode, thanks so much for the opportunity to join, and for the insightful conversation!

EACR - European Association for Cancer Research@helloeacr.bsky.social · last yr.

🚨 New podcast episode! In this insightful and honest conversation, award winners Karin de Visser, Ido Amit and @martakova.bsky.social talk about their research, career journeys, and excitement for the future of cancer research: magazine.eacr.org/curiosity-op...

What an honor it was for me to be interviewed for the EACR The Cancer Researcher Magazine shorturl.at/6Z4y1 Looking forward to seeing you all and feeling that buzz in Lisbon in just a couple of short months!

"Open many doors and follow the path that seems most promising": Interview with Marta Kovatcheva, winner of the EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 2025 - The Cancer Researcher

Marta Kovatcheva is the 2025 winner of the EACR-Mark Foundation-Pezcoller Foundation Rising Star Award, and recently shared with us some valuable advice for fellow cancer researchers.

shorturl.at

EACR - European Association for Cancer Research@helloeacr.bsky.social · last yr.

Don't miss the #EACR2025 early registration rate deadline in just a few short weeks! Taking place this year in the vibrant city of Lisbon, we're proud to invite you to Europe’s leading cancer research conference 🥳 2025.eacr.org

"Cancer knows no borders, and setbacks in one part of the world can have lasting consequences for patients everywhere" Science is a global effort and we must continue to make it such, especially in the face of political attempts to dismantle & destroy it.

EACR - European Association for Cancer Research@helloeacr.bsky.social · last yr.

The EACR stands against threats to cancer research. Protecting scientific research is vital for progress and and the development of new treatments. Read our full statement in support of our friends and colleagues in the US: eacr.org/statement-on...

Today more than any year before (in my short life as a scientist), Happy International Day of Women and Girls in Science!!! 🦠💅🧫🧪👩‍🔬. Cheers to all the strong, brilliant women who inspire me, the men who are true allies, and everyone who refuses to doubt that diversity truly makes us better.

I am incredibly honored and excited to receive this award, thank you so much to @helloeacr.bsky.social @themarkfdn.bsky.social and Pezcoller Foundation for this opportunity!!

The Mark Foundation for Cancer Research@themarkfdn.bsky.social · 2y ago

Congratulations to @martakova.bsky.social, winner of the 2025 @helloeacr.bsky.social-Mark Foundation-Pezcoller Foundation Rising Star Award!🌟 Kovatcheva, the award’s third recipient, will use her funding to support work on epithelial cell plasticity. Learn more: themarkfoundation.org/2025/01/54273/

Congratulations to @valeramponi.bsky.social for this important, innovative, and visually beautiful work that significantly advances our understanding of the diverse cell states that can emerge in tumors post-therapy 👏🌟 and check out that @theaacr.bsky.social cover illustration 🤩❤️😉

@valeramponi.bsky.social · 2y ago

I am thrilled to finally share our work on persister cancer cells: we identify distinctive features and actionable #vulnerabilities ⚡️of persister cancer cells (#DTP), and provide mechanistic insight into their low #inflammatory activity: aacrjournals.org/cancerres/ar...

2024 has been truly a "dream come true" year for me, getting to start my own lab at IFOM. I'm honored to share my reflections on this transition, alongside these 11 other exciting new PIs. Thank you, @naturecancer.bsky.social, for the opportunity to keep it real 😉

Nature Cancer@natcancer.nature.com · 2y ago

⭐️If you haven't yet done so, check out our 2024 year-in-review Focus Issue now! 🔗https://nature.com/collections/chiegfhchj Featuring: *Editorial on 2024 #cancerresearch highlights *#newPIs Viewpoint *#AI and #spatialomics in #oncology *(CAR-)T cell therapies in cancer *12 Research Highlights

Redacting names on PI applications to see if it could help gender parity. The result? "All five [of 5 open positions] went to women during the study, compared with just one during the earlier period." Implicit bias is very real. www.nature.com/articles/d41...

How a biochemistry department used redacted job applications to achieve gender parity

Anonymizing job applications before shortlisting helped to boost the number of women appointed.

nature.com

This the season 🌟🌲🎅🥂🎁🎄🎇 Our first lab holiday party, complete with a hotpot feast, lots of wine, and Secret Santa gifts so thoughtful and perfect, you'd never guess we've all known each other for less than a month ❤️ Excited to see what 2025 will hold for this crew ✨

Bild